MEREO BIOPHARMA GROUP PLC Adjustments For Increase Decrease In Trade Account Payable
MEREO BIOPHARMA GROUP PLC (MREO) reported Adjustments For Increase Decrease In Trade Account Payable of GBP 1.60 million for the 12-month period ending 2018-12-31, per its 20-F/A filed 2019-05-29.
Discontinued › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2019-05-29
| Period end | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|
| 2018-12-31 | 1.60M GBP 20-F/A · filed 2019-05-29 |
| 2017-12-31 | 3.86M GBP 20-F/A · filed 2019-05-29 |
| 2016-12-31 | -768.40K GBP 20-F/A · filed 2019-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |